Management of Thrombocytopenia in Patients with Chronic Liver Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Thrombocytopenia in Patients with Chronic Liver Disease
Authors
Keywords
Chronic liver disease, Cirrhosis, Thrombocytopenia, Thrombopoietin receptor agonists, Platelets transfusion, Treatment algorithm
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-22
DOI
10.1007/s10620-019-05615-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2)
- (2019) Markus Peck‐Radosavljevic et al. HEPATOLOGY
- Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis
- (2018) Lorenzo Loffredo et al. DIGESTIVE AND LIVER DISEASE
- Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia
- (2018) Norah Terrault et al. GASTROENTEROLOGY
- Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2018) Charles A. Schiffer et al. JOURNAL OF CLINICAL ONCOLOGY
- Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures
- (2018) Hisashi Hidaka et al. Clinical Gastroenterology and Hepatology
- Platelets in liver disease, cancer and regeneration
- (2017) Tomohiro Kurokawa et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Management of Thrombocytopenia in Advanced Liver Disease
- (2016) VGR Gangireddy et al. Canadian Journal of Gastroenterology and Hepatology
- Lusutrombopag: First Global Approval
- (2015) Esther S. Kim DRUGS
- Management of thrombocytopenia due to liver cirrhosis: A review
- (2014) Hiromitsu Hayashi WORLD JOURNAL OF GASTROENTEROLOGY
- Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy
- (2013) Nezam H. Afdhal et al. GASTROENTEROLOGY
- Coagulopathy in cirrhosis – The role of the platelet in hemostasis
- (2013) Elliot B. Tapper et al. JOURNAL OF HEPATOLOGY
- Adverse events of upper GI endoscopy
- (2012) Tamir Ben-Menachem et al. GASTROINTESTINAL ENDOSCOPY
- Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis
- (2012) Mohamed M Moussa et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Image-guided Interventions
- (2012) Indravadan J. Patel et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
- (2012) Nezam H. Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patients
- (2011) Fred Poordad et al. JOURNAL OF MEDICAL ECONOMICS
- Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver Disease
- (2010) Edoardo G. Giannini et al. Clinical Gastroenterology and Hepatology
- Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial
- (2010) Leonard B. Seeff et al. Clinical Gastroenterology and Hepatology
- Use of Thrombopoietic Agents for the Thrombocytopenia of Liver Disease
- (2010) Hans L. Tillmann et al. SEMINARS IN HEMATOLOGY
- Liver biopsy
- (2008) Don C. Rockey et al. HEPATOLOGY
- Thrombocytopenia associated with chronic liver disease
- (2008) Nezam Afdhal et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started